MX2020003571A - Una composicion antimicrobiana. - Google Patents

Una composicion antimicrobiana.

Info

Publication number
MX2020003571A
MX2020003571A MX2020003571A MX2020003571A MX2020003571A MX 2020003571 A MX2020003571 A MX 2020003571A MX 2020003571 A MX2020003571 A MX 2020003571A MX 2020003571 A MX2020003571 A MX 2020003571A MX 2020003571 A MX2020003571 A MX 2020003571A
Authority
MX
Mexico
Prior art keywords
antimicrobial composition
composition
protein
sericin
zein
Prior art date
Application number
MX2020003571A
Other languages
English (en)
Inventor
Amitava Pramanik
Somnath Das
Original Assignee
Unilever Ip Holdings B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Ip Holdings B V filed Critical Unilever Ip Holdings B V
Publication of MX2020003571A publication Critical patent/MX2020003571A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe una composición antimicrobiana que comprende piritiona de zinc y cristales modificados habituales de óxido de zinc que de preferencia comprenden partículas atrapadas de una proteína soluble en agua. La proteína se puede seleccionar de al menos uno de sericina, albúmina de suero bovino, gelatina, albúmina de huevo, caseína, zeína, suero o lisozima. La composición se puede utilizar para la limpieza personal y se prefiere especialmente que se suministre como un champú o acondicionador para el cabello.
MX2020003571A 2017-09-29 2018-08-27 Una composicion antimicrobiana. MX2020003571A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17194025 2017-09-29
PCT/EP2018/072995 WO2019063222A1 (en) 2017-09-29 2018-08-27 ANTIMICROBIAL COMPOSITION

Publications (1)

Publication Number Publication Date
MX2020003571A true MX2020003571A (es) 2020-08-03

Family

ID=59997240

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020003571A MX2020003571A (es) 2017-09-29 2018-08-27 Una composicion antimicrobiana.

Country Status (7)

Country Link
US (1) US20200253845A1 (es)
EP (1) EP3687481B1 (es)
JP (1) JP7175970B2 (es)
CN (1) CN111163751B (es)
BR (1) BR112020005043B1 (es)
MX (1) MX2020003571A (es)
WO (1) WO2019063222A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200397673A1 (en) * 2017-12-20 2020-12-24 Conopco, Inc., D/B/A Unilever An antimicrobial composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810799D0 (en) * 1998-05-21 1998-07-15 Boots Co Plc Antimicrobial agent
BR0011852A (pt) * 1999-06-25 2002-04-30 Arch Chem Inc Composições tópicas para o tratamento de infecções microbianas na pele ou couro cabeludo
US20040058855A1 (en) 2002-04-22 2004-03-25 Schwartz James R. Use of materials having zinc ionophoric behavior
US20040191331A1 (en) 2003-03-18 2004-09-30 The Procter & Gamble Company Composition comprising particulate zinc materials having a defined crystallite size
US20110070275A1 (en) * 2008-05-30 2011-03-24 Yasuhiro Hidaka Crystalline pyrithione/zinc oxide composite and physiologic/antibiotic composition containing the same
JP6008382B2 (ja) * 2012-03-14 2016-10-19 住化エンバイロメンタルサイエンス株式会社 工業用抗菌組成物
CN104017393A (zh) 2014-06-11 2014-09-03 安徽恒昊科技有限公司 一种纳米氧化锌包覆绢云母粉复合材料及其制备方法
JP6164707B1 (ja) * 2016-02-10 2017-07-19 学校法人同志社 抗菌性を有する酸化亜鉛粉体の製造方法

Also Published As

Publication number Publication date
CN111163751A (zh) 2020-05-15
WO2019063222A1 (en) 2019-04-04
EP3687481B1 (en) 2022-12-28
US20200253845A1 (en) 2020-08-13
EP3687481A1 (en) 2020-08-05
CN111163751B (zh) 2023-05-02
JP7175970B2 (ja) 2022-11-21
BR112020005043B1 (pt) 2023-01-10
JP2020535137A (ja) 2020-12-03
BR112020005043A2 (pt) 2020-09-15

Similar Documents

Publication Publication Date Title
CL2020002043A1 (es) Métodos y composiciones para la entrega de proteínas terapeuticas.
MX2022013526A (es) Degradadores de proteinas y usos de los mismos.
EP3897524A4 (en) PROTEIN MICROCAPSULES AND THEIR PREPARATION METHOD
IL279510A (en) Progranulin-FC polypeptide fusion proteins and their uses
EA201890790A1 (ru) Связывающие pd-1 белки и способы их применения
IL266517A (en) A method for increasing the secretion levels of interleukin 2 and proteins derived from it
EP3958683A4 (en) RECOMBINANT MILK PROTEINS AND COMPOSITIONS COMPRISING THEM
WO2017135791A8 (en) Anti-c-met antibodies and uses thereof
MX2020000018A (es) Potencializacion de componentes sanguineos de actividad anti-bacteriana de proteina litica y metodos y usos de estos.
CL2020002012A1 (es) Formulaciones de anticuerpos humanos anti-rankl y métodos de uso de estas. (divisional solicitud 201903032)
MX2020011333A (es) Uso terapeutico de proteinas morfogeneticas oseas.
BR112017018929A2 (pt) uso de um probiotico e um peptídeo derivado de beta-lactoglobulina, composição, kit de peças, método para induzir tolerância oral, e/ou tratamento, prevenção ou redução do risco de ocorrência de alergia em um indivíduo
WO2016061504A3 (en) Recombinant antibodies that recongnize the c-terminal domains of ebola virus nucleoprotein
WO2020123795A3 (en) Anellosomes for delivering protein replacement therapeutic modalities
EA201991015A1 (ru) Модифицированные пептиды
WO2018071583A3 (en) Humanized anti-muc1* antibodies and use of cleavage enzyme
IL279117A (en) Antibodies against disease-causing agents in aquaculture and their use
MX2018013372A (es) Metodo de microdilucion en caldo para evaluar y determinar la concentracion inhibitoria minima de polipeptidos antibacterianos.
EA202190999A1 (ru) Композиции на основе полипептидов, стабилизированных с помощью дисульфидной связи, и способы применения
CL2018002785A1 (es) Composición para el control de microsporidia en peces y procedimiento para el control de microsporidia en peces utilizando dicho procedimiento.
MX2020003571A (es) Una composicion antimicrobiana.
WO2019094533A8 (en) Angptl8-binding agents and methods of use thereof
EP3976017A4 (en) PHARMACOLOGICAL SUBSTANCES FOR THE TREATMENT OF PROTEIN AGGREGATION DISEASES OF THE EYE
EP4089105A3 (en) Allergy antigen and epitope for same
EP3863655A4 (en) Lactococcus lactis expression system for delivering proteins efficacious for the treatment of epithelial barrier function disorders